These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1424 related articles for article (PubMed ID: 18286529)

  • 41. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas.
    Kobatake T; Yano M; Toyooka S; Tsukuda K; Dote H; Kikuchi T; Toyota M; Ouchida M; Aoe M; Date H; Pass HI; Doihara H; Shimizu N
    Oncol Rep; 2004 Nov; 12(5):1087-92. PubMed ID: 15492797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.
    Wilcox CB; Baysal BE; Gallion HH; Strange MA; DeLoia JA
    Cancer Genet Cytogenet; 2005 Jun; 159(2):114-22. PubMed ID: 15899382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer.
    McDaid HM; Cairns MT; Atkinson RJ; McAleer S; Harkin DP; Gilmore P; Johnston PG
    Br J Cancer; 1999 Feb; 79(5-6):933-9. PubMed ID: 10070893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation.
    Valleley EM; Cordery SF; Carr IM; MacLennan KA; Bonthron DT
    Genes Chromosomes Cancer; 2010 May; 49(5):480-6. PubMed ID: 20175198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of GATA-4/-5 transcription factors in ovarian carcinogenesis.
    Wakana K; Akiyama Y; Aso T; Yuasa Y
    Cancer Lett; 2006 Sep; 241(2):281-8. PubMed ID: 16337738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
    Kim M; Lee KT; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Kim SY; Yoo HS; Kim YS
    Mol Cancer Res; 2008 Feb; 6(2):222-30. PubMed ID: 18314483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
    Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
    Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization.
    Shridhar V; Sen A; Chien J; Staub J; Avula R; Kovats S; Lee J; Lillie J; Smith DI
    Cancer Res; 2002 Jan; 62(1):262-70. PubMed ID: 11782386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opioid-binding protein/cell adhesion molecule-like (OPCML) gene and promoter methylation status in women with ovarian cancer.
    Czekierdowski A; Czekierdowska S; Szymanski M; Wielgos M; Kaminski P; Kotarski J
    Neuro Endocrinol Lett; 2006 Oct; 27(5):609-13. PubMed ID: 17159813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma].
    Zhang J; Li YH; Cui AR; Wang JL; Cheng JX; Wang SJ
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):905-9. PubMed ID: 19173990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis.
    Weber F; Aldred MA; Morrison CD; Plass C; Frilling A; Broelsch CE; Waite KA; Eng C
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1149-55. PubMed ID: 15546898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hypermethylation of promoter region of RASSF1A gene in ovarian malignant epithelial tumors].
    Ma L; Zhang JH; Liu FR; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):657-9. PubMed ID: 16438885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
    Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
    Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity.
    Guarcello V; Blanquicett C; Naguib FN; El Kouni MH
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):85-96. PubMed ID: 17805539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Role of Methylation in the CpG Island of the ARHI Promoter Region in Cancers.
    Liu X; Zhang T; Li Y; Zhang Y; Zhang H; Wang X; Li L
    Adv Exp Med Biol; 2020; 1255():123-132. PubMed ID: 32949395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.
    Wanajo A; Sasaki A; Nagasaki H; Shimada S; Otsubo T; Owaki S; Shimizu Y; Eishi Y; Kojima K; Nakajima Y; Kawano T; Yuasa Y; Akiyama Y
    Gastroenterology; 2008 Aug; 135(2):580-90. PubMed ID: 18588891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.